Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. H&R GmbH KGaA's interest expense for the
three
months ended in Mar. 2026 was € -3 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was €-11 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
H&R GmbH KGaA Interest Expense Historical Data
* Premium members only.
The historical data trend for H&R GmbH KGaA's Interest Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-11 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H&R GmbH KGaA (WBO:2HRA) has a Interest Expense of €-11 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on H&R GmbH KGaA and its competitors.
Is H&R GmbH KGaA's Interest Expense too high?
H&R GmbH KGaA's current Interest Expense is €-11 Mil. Overall, H&R GmbH KGaA has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does H&R GmbH KGaA's Interest Expense compare to LIN and SHW?
H&R GmbH KGaA's Interest Expense of €-11 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Chemicals company?
A good Interest Expense depends on the Chemicals industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on H&R GmbH KGaA and its competitors. H&R GmbH KGaA's current Interest Expense is €-11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H&R GmbH KGaA stock overvalued right now?
Based on GuruFocus' analysis, H&R GmbH KGaA (WBO:2HRA) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.25, compared to a current price of €6.46 — trading 52% above its estimated fair value. The current Interest Expense is €-11 Mil. H&R GmbH KGaA's overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For H&R GmbH KGaA (WBO:2HRA), the current Interest Expense is €-11 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H&R GmbH KGaA (WBO:2HRA) Overvalued in 2026?
Based on GuruFocus' analysis, H&R GmbH KGaA stock appears to be overvalued.
The current stock price of €6.46 is trading 52% above its estimated GF Value™ of €4.25.
GuruFocus considers H&R GmbH KGaA to be Significantly Overvalued.
Key valuation signals for WBO:2HRA:
Interest Expense: €-11 Mil
GF Value™: €4.25 vs. price of €6.46 (52% above fair value)
No single metric tells the full story. See the WBO:2HRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
H&R GmbH & Co KGaA is a manufacturer of chemical-pharmaceutical specialty products. The company organizes its operating activities into two business divisions: Chemical-Pharmaceutical Raw Materials and Plastics. It also has three business segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment produces specialty products from crude oil in the two domestic refineries (Hamburg-Neuhof and Salzbergen). Its ChemPharm Sales segment encompasses the production sites abroad as well as international sales activities. The company's Plastics segment manufactures high-precision plastic parts along with the associated tools and molds. The company derives a majority of its revenue from the ChemPharm Refining segment. Geographically, it derives key revenue from Germany.
40GF Score
Get the complete analysis for WBO:2HRA
Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:2HRA has been successfully added to your 
